Navigation Links
ABAXIS Announces Worldwide Animal Health Licensing Agreement for Rapid Test Technology
Date:1/7/2009

th the United States Securities and Exchange Commission. Forward-looking statements speak only as of the date the statement was made. Abaxis does not undertake and specifically disclaims any obligation to update any forward-looking statements. 

    Contact:  Clint Severson             Lytham Partners, LLC
              Chief Executive Officer    Joe Dorame, Robert Blum and Joe Diaz
              Abaxis, Inc.               602-889-9700
              510-675-6500


'/>"/>
SOURCE Abaxis, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Abaxis, Inc. to Present at the RBC Capital Markets 2008 Healthcare Conference
2. Abaxis Reports Record Revenues and Operating Income for the Second Quarter of Fiscal 2009
3. Abaxis, Inc. to Present at the Sidoti & Companys Seventh Annual West Coast Emerging Growth Institutional Investor Forum
4. Abaxis Reports Financial Performance for the First Quarter of Fiscal 2009
5. Abaxis to Report Third Quarter Fiscal 2008 Financial Results Thursday, January 31, 2008
6. Abaxis CEO Clint Severson Named Entrepreneur of the Year by Forbes Magazine
7. Abaxis to Present at the Sidoti & Company Sixth Annual San Francisco Institutional Investor Forum Conference
8. Cell Therapeutics Announces Receipt of NASDAQ Panel Decision to Transfer to NASDAQ Capital Market
9. Horizon Therapeutics Announces Senior Management Appointments
10. BioSpecifics Technologies Corp. Announces Listing on NASDAQ Global Market
11. Star Scientific Announces Successful Completion of Product Satisfaction Study - Results Show Potential for Development and Manufacturing of New Pharmaceutical Product for Smoking and Smokeless Tobacco Cessation

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...0 Veridiam (www.veridiam.com) won ...any category at the 2009 Workplace Excellence Awar...ety for Human Resources Management and recognize i...s. ,, Veridiam was one of nine winners, selecte... honored at the recent awards ceremony. San Diego-...
(Date:11/20/2009)...TTLER TOLEDO recently announced that a free webina...Using At-Line Particle Characterization”, wi...nar, the application of in situ particle character...d optimize a series of roller compaction runs whil...mpaction forces. , (PRWEB...
(Date:11/19/2009)...ov. 19 Dr. Mate Hidvegi, inventor ...o a press release issued on November 17 by Biropha...king false and self-serving statements about its U...dvegi stated from his office in Budapest, Hungary:...mar does not apply to AveULTRA, www.aveultra.com...
(Date:11/19/2009)...ermany, November 19 MONITORING FOR... 16th, 2009 Flibanserin in the,indication treatmen...n,s,disease for orphan drug status designation wit...nduced dyskinesia is a complication of the mainsta...burden to some of those,affected, since it may be ...
Breaking Biology Technology:Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category 2Roller Compaction Process Optimization Using At-Line Particle Characterization 2American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2
...if., Oct. 11 CV Therapeutics,Inc. (Nasdaq: CVTX ...er,financial results for 2007 after the market clo...t will webcast a conference call at 4:30 p.m. EST,...s the live webcast, please log on to the Company,s...estor Information section. Alternatively,domestic ...
...ON, QC, Oct. 11 /PRNewswire-FirstCall/ - The Board... announce the appointment of,Mr. James A. Northrop...ve,November 5, 2007. A member of the Board of Dir...ed chief executive with a record of success in rap...experience in the direct selling,consumer packaged...
...ct. 11 Access Genetics, an Eden Prairie-,based mo..., announced today,that it has appointed Paul J. Ho...- Legal, Quality and Regulatory. Mr. Hoedeman was...sly,served as VP of Finance at Home Depot, CFO and...troller of NCR Corporation. He holds a J.D.,from W...
Other Biology Technology:CV Therapeutics To Announce 2007 Third Quarter Financial Results on Tuesday, November 6, 2007 2Immunotec Inc. announces appointment of President & CEO James A. Northrop 2Access Genetics Announces New Executive Appointments 2
(Date:11/20/2009)...ction of flax shives, and generated from Brassica...se which engulf fields in spring, can be used to p...studies carried out by Spanish and Dutch researche...tainable Energy Reviews . , "These studies evalua...ction of bioethanol from two, as yet unexploited s...
(Date:11/20/2009)...earch Center (ERC) has been awarded a grant from t...ods of recovering and reusing the heat that would ...sion process in a carbon capture system. The goal ...pture and sequestration, or storage (CCS), and thu...tted into the atmosphere by coal-fired power plant...
(Date:11/19/2009)...in chemical with an unwieldy name: 4-hydroxybutyra...d as a date-rape drug. , Now, a team of Ohio an...y which 4-HB is metabolized by the body. "This is ...bson, professor and chair of biological sciences a...f the research team. "It may provide new clues on...
Breaking Biology News(10 mins):Flax and yellow flowers can produce bioethanol 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 3Researchers begin to decipher metabolism of sexual assault drug 2Michael Jackson Joins Tragic List of Accidental Celebrity Deaths Caused by Prescription Drugs Says eDrugSearch com 50214 1Michael Jackson Joins Tragic List of Accidental Celebrity Deaths Caused by Prescription Drugs Says eDrugSearch com 50214 2Michael Jackson Joins Tragic List of Accidental Celebrity Deaths Caused by Prescription Drugs Says eDrugSearch com 50214 3Michael Jackson Joins Tragic List of Accidental Celebrity Deaths Caused by Prescription Drugs Says eDrugSearch com 50214 4Takeda Receives FDA Complete Response Letter for Alogliptin an Investigational Treatment for Type 2 Diabetes 4658 1Takeda Receives FDA Complete Response Letter for Alogliptin an Investigational Treatment for Type 2 Diabetes 4658 2Sanofi aventis Stands Behind the Safety of Lantus 28R 29 4657 1Sanofi aventis Stands Behind the Safety of Lantus 28R 29 4657 2Sanofi aventis Stands Behind the Safety of Lantus 28R 29 4657 3
...is created in this cool movie , ,Scientists at ... (NIST) have created polymer nanotubes that are un...e enough to maintain their shape indefinitely. Des...al Academy of Sciences,* the NIST nanotubes may ha... volumes of chemicals in nanofluidic reactor devic...
...stem cells given to animals that have neurological... a stroke or newborns with cerebral palsy can sign...uries, researchers say. , Using a commonly utilize...d a dose of 200,000-400,000 human stem cells into ...ant loss of mobility and other functions. The ste...
...etective work. Biology researchers at Lewis & ...ound evidence for an ancient transfer of a toxin b...-spiders and a bacterium. But the mystery remains ... Their research is published this month in the jou... titled "Lateral gene transfer of a dermonecrotic ...
Other Biology News:Stable polymer nanotubes may have a biotech future 2Stem cell transplants improve recovery in animal models for stroke, cerebral palsy 2Stem cell transplants improve recovery in animal models for stroke, cerebral palsy 3Stem cell transplants improve recovery in animal models for stroke, cerebral palsy 4Stem cell transplants improve recovery in animal models for stroke, cerebral palsy 5Evolution mystery: Spider venom and bacteria share same toxin 2
Stains-All from Sigma-Aldrich
MutaPLATE Salmonella sp. from Alpco Diagnostics
...EPICENTREs patented MasterAmp™ 10X PCR Enhanc...rmance and allows improved sensitivity and specifi...g MasterAmp™ PCR Enhancer in PCR eliminates t..., increases enzyme?s thermal stability, suppresses...
...Application: The simple three step procedure (PCR,...sformation) can be completed in one day. The typic... than 80%. , Features and Benefits: , , Universal ...ector , High Cloning Efficiency - Typically>80% , ...
Biology Products: